Trial Management STREAM

  1. Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites 3/12/2021

    Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies on a collaborative portal more than 6 years ago and leveraging technology to deliver results.